CORE--TRANSGENIC ANIMALS
核心——转基因动物
基本信息
- 批准号:6573087
- 负责人:
- 金额:$ 13.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2003-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Description
The primary aim of this Core is to coordinate the use of animals needed
by investigators of each of the five projects of this Program Project.
Activities include 1) the procurement of animals either from commercial
vendors or the production of (mRen-2)27 and Hannover SD (SD) rats from
breeder animals maintained by this core facility, 2) the maintenance of
a homozygous (mRen-2)27 transgenic rat colony and SD rat colony, 3) the
coordination of housing provided by the Animal Resources Program (ARP)
at the Wake Forest University School of Medicine of all animals used by
investigators of this Program Project grant, and 4) to assist
investigators in the preparation of animals for experiments proposed in
this Program Project grant. Finally, Program Project investigators may
consult with Drs. Averill (Project Leader) and Strawn (Project Co-
investigator) in the choice of other animal models as the need arises
based upon the outcome of studies in this Program Project grant.
The experiments described in this Program Project will, in part, use
hemizygous (mRen-2)27 transgenic or Han SD rats. Hemizygous (mRen-2)27
transgenic rats are offspring of a homozygous (mRen-2)27 male rat mated
with a female SD rat. These hemizygous (mRen-2)27 transgenic
hypertensive rats are referred to as production hemizygous animals
(TG*). It is estimated that the animal facility associated with the Core
will deliver approximately 325 Tg+ and 350 SD rats per year to Program
Project investigators during the proposed 5 year term of this Program
Project renewal. In addition, the Core will coordinate the use for the
approximately 145 SHR and 140 WKY rats which will be used yearly by
Program Project investigators.
描述
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID B AVERILL其他文献
DAVID B AVERILL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID B AVERILL', 18)}}的其他基金
ROLE OF TISSUE ANGIOTENSINS IN THE MEDULLA OBLONGATA
组织血管紧张素在延髓中的作用
- 批准号:
6272954 - 财政年份:1998
- 资助金额:
$ 13.19万 - 项目类别:
ROLE OF TISSUE ANGIOTENSINS IN THE MEDULLA OBLONGATA
组织血管紧张素在延髓中的作用
- 批准号:
6242318 - 财政年份:1997
- 资助金额:
$ 13.19万 - 项目类别:
ROLE OF TISSUE ANGIOTENSINS IN THE MEDULLA OBLONGATA
组织血管紧张素在延髓中的作用
- 批准号:
3737224 - 财政年份:
- 资助金额:
$ 13.19万 - 项目类别:
ROLE OF TISSUE ANGIOTENSINS IN THE MEDULLA OBLONGATA
组织血管紧张素在延髓中的作用
- 批准号:
3759233 - 财政年份:
- 资助金额:
$ 13.19万 - 项目类别:
ROLE OF TISSUE ANGIOTENSINS IN THE MEDULLA OBLONGATA
组织血管紧张素在延髓中的作用
- 批准号:
5214148 - 财政年份:
- 资助金额:
$ 13.19万 - 项目类别:














{{item.name}}会员




